EZR-104 FDA Approval Status
FDA Approved: No
Brand name: EZR-104
Generic name: valsartan
Company: Ezra Innovations, LLC
Treatment for: High Blood Pressure, Heart Failure
EZR-104 (valsartan) is a novel formulation of the angiotensin receptor blocker valsartan, with patented RubiretenTM delivery technology, in development for the treatment of hypertension and heart failure.
Development timeline for EZR-104
| Date | Article |
|---|---|
| Jan 18, 2017 | Ezra Announces FDA Acceptance of Filing of New Drug Application For EZR-104 for the Treatment of Hypertension and Heart Failure |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
